Nuclear extracts, prepared from Autographa californica nuclear polyhedrosis virus-infected Spodoptera frugiperda cells during a time course of infection, were analyzed for activation of early gene transcription and for late gene transcription. The templates used in the in vitro transcription assays contained promoters for baculovirus genes that have been classified as immediate early, delayed early, and late. The promoters were derived from the baculovirus 39K, p26, gp64, and DNA polymerase genes. In addition, the adenovirus major late promoter was included in these studies. We found that transcription from promoters classified as immediate early or delayed early was accurately initiated by using extracts from uninfected cells. Furthermore, transcription from all early promoters tested was found to be transactivated by nuclear extracts prepared at 4 and 8 h postinfection. However, baculovirus enhancer-dependent transcriptional activation was not observed in tests with templates containing the hr5 enhancer sequence. Transcription from baculovirus late promoters was also not observed. A decline in transcription by nuclear extracts prepared from cells late in infection was associated with the presence of DNase activity.
The Baculoviridae are a family of insect viruses characterized by a complex replication cycle that culminates in the occlusion of virions in a crystalline protein matrix (3) . The Autographa califonica multicapsid nuclear polyhedrosis virus (AcMNPV) is the most well-characterized baculovirus and has a double-stranded, circular, supercoiled DNA genome of approximately 128 kbp. Progression through the AcMNPV infection cycle is governed by a cascade of early, late, and very late gene transcription (7) . Early transcription begins before the initiation of replication of the viral genome and is inhibited by o-amanitin, consistent with it being RNA polymerase II dependent. Investigations with reporter gene constructs transfected into insect cells suggest that the level of transcription from early gene promoters is modulated by viral transactivating factors (4, 5, 10, 23) and enhancer sequences (12, 18, 22) . After initiation of viral DNA replication, late gene expression is initiated and the transcription of some host nuclear genes is repressed (19) . Very late in infection, two genes involved in occlusion body formation (polyhedrin and plO) are hyperexpressed (for a review, see reference 3). The transcription of late genes is dependent on the presence of an a-amanitin-resistant RNA polymerase (8, 9, 16 ) having a unique subunit composition that is differcnt from those of the three host RNA polymerases (26).
Although one of the most intriguing aspects of baculovirus replication concerns the control of the viral transcription cascade, few of the host and viral factors participating in the regulation of baculovirus gene expression have been identified. The development of in vitro systems that reflect in vivo gene transcription is crucial for the identification and analysis of these factors. We have recently reported that baculovirus genes classified as immediate early are accurately initiated by nuclear extracts from uninfected insect (Spodoptera frugiperda [Sf9] ) and human (Namalwa) cells (15) . In these studies, we concluded that host cell RNA polymerase II and its associated factors were the only components required for basal transcription from baculovirus immediate-early promoters. Wc have now cxtended these initial studies to cxamine in vitro transcription, using nuclear extracts prepared from both uninfected and AcM NPV-infected Sf9 cells. Uninfected-cell nuclear extracts were tested for the ability to support the transcription of genes categorized as immediate early or delayed early, whereas nuclear extracts from infected cells were examined for the transactivation of early gene transcription and for latc promoter-dependent transcription. We also tested for baculovirus hrS enhancer sequence-dependent transcription in vitro. Finally, we compared the relative levels of in vivo and in vitro transcription from a specific promoter at various times after infection.
MATERIALS AND METHODS
Construction of templates. The templates constructed for this study are described below and are shown in Fig. 1 . These templates were derived from the genomcs of AcM NPV, Orgyia pseludotsutgata multicapsid nuclcar polyhcdrosis virus (OpMNPV), and adenovirus type 2. The sequence of the promoter and mRNA initiation regions of these genes is shown in Fig. 5 .
(i) AcMNPV 39K gene promoter (p39K). Plasmid p39K contains a 1-kb PstI-SstI fragment from the AcMNPV PstI K fragment (10) cloned into the corresponding restriction sitcs of pBlucscript (pKS-; Stratagcnc Cloning Systcms).
(ii) 39K gene promoter plus enhancer hr5 (pHR39K Tests for the presence of nucleases. To test for RNase activity in the nuclear extracts, radioactively labeled RNA was made in a standard transcription reaction mixture using an uninfected-cell nuclear extract with SstI-digested pHR39K ( Fig. 1A) as template DNA. After the normal incubation time, the reaction mixture was divided into four aliquots and treated as follows. One aliquot was stopped immediately by the addition of stop buffer. To the second aliquot, RNase A was added to a final concentration of 1 ,ug/,ul and incubated for a further 10 min at 30°C. To the third aliquot, uninfected extract was added at a concentration of 30% of total reaction volume, and the reaction was incubated for a further 30 min at 30°C. This reaction tested for the presence of RNase activity in the uninfected-cell nuclear extract. The fourth aliquot was used to test for RNase activity in late infected-cell nuclear extracts. This was done by mixing it with a nuclear extract prepared at 34 h p.i. at a final concentration of 30% of the total reaction volume and incubating for 30 min at 30°C. All samples were then processed like standard in vitro transcription reactions and analyzed by polyacrylamide gel electrophoresis and autoradiography.
To test for DNase activity, mock transcription reactions were prepared in which SstI-digested pHR39K template DNA (30 ,ug/ml) was incubated with nuclear extracts (3 mg/ml) produced at various times postinfection. Two reactions for each extract sample were prepared, and EDTA was added at a final concentration of 10 mM to one of the samples. After incubation for 60 min at 30°C, the DNA templates were purified by extraction with phenol and precipitation with ethanol. Samples were loaded onto an agarose gel in sample buffer containing RNase A (100 p,g/ml) to remove RNA present in nuclear extracts. After electrophoresis, the DNA was stained with ethidium bromide and photographed on a UV transilluminator.
RESULTS
Rationale for templates used for in vitro transcription. The purpose of this investigation was to determine whether the transcriptional events observed during the baculovirus infection cycle were mirrored by the in vitro transcription system. The transcriptional processes investigated and the gene promoters included in these studies are listed as follows. (i) Gene class: the genes selected are examples of promoters termed in the literature as immediate early, delayed early, early, and late. (ii) Promoter structure: the AcMNPV DNA polymerase gene was investigated because unlike several other baculovirus early promoters it lacks a conventional TATA promoter element (see Fig. 5 ). (iii) Transactivation: the AcMNPV 39K and OpMNPV gp64 genes were employed because they both have been shown to be transactivated in vivo (4, 11) . (iv) Enhancement by hr sequences: the AcM NPV 39K gene was used as a template because it is enhanced by hr sequences (12) . The AcMNPV p26 gene was investigated because it is next to an enhancer sequence (hr5) in its native location (17) . The OpMNPV p26 gene (1) has a sequence similar to that of the AcMNPV p26 gene but lacks an adjacent enhancer sequence and would allow examination of the influence of enhancer proximity for comparison to the AcMNPV p26 gene. (v) A non-baculovirus promoter: the adenovirus major late promoter was employed because it is commonly used for investigations of transcription in higher eukaryotes and would allow comparison of events occurring in baculovirus-infected cell extracts to better-characterized systems.
In vitro transcription by nuclear extracts from uninfected Sf9 cells. Previously, it was demonstrated that plasmids containing promoters from the OpMNPV gp64, AcAMNPV IE-1 (a gene that encodes a transactivating factor) (13), and the adenovirus major late genes are transcribed by nuclear extracts from uninfected Sf9 cells (15) . In these assays they behaved as immediate-early genes. In order to characterize the transcription of early promoters in vitro, the ability of nuclear extracts from uninfected Sf9 cells to transcribe a variety of other baculovirus genes was compared with in vitro transcription of the gp64 and adenovirus major late promoter constructs previously investigated. The constructs used in these investigations included 5' regulatory sequences of genes reported to be (i) immediate early (the gp64 promoter p64CAT-319) (15); (ii) early (the DNA polymerase promoter pDNAP) (24); (iii) delayed early (the 39K promoters p39K and pHR39K) (11); the AcMNPV p26 promoter (16) pAcHRp26 and the OpMNPV p26 promoter pOpp26 (1); and (iv) a commonly used RNA polymerase II promoter (the adenovirus major late promoter pAML). For constructs see Fig. 1 . All these templates gave runoff transcripts of the expected sizes when used in the in vitro transcription system with uninfected nuclear extracts ( Fig. 2A through F , lanes 1). Primer extension analyses confirmed that the transcripts initiated at the same position both in vitro and in vivo (see below). Whereas the p64CAT-319, pHR39K, and pAML promoter templates produced strong signals, runoff transcripts from pDNAP, pAcHRp26, and pOpp26 were detected at a lower level ( Fig. 2A through F, lanes 1) . These experiments indicate that nuclear extracts from uninfected Sf9 cells accurately initiate and elongate RNA from the promoters of these genes. This suggests that basal levels of in vitro transcription from these promoters are dependent solely on host enzymes and transcription factors. Transactivation of transcription by nuclear extracts from AcMNPV-infected Sf9 cells. In vitro transcription of templates was examined by using Sf9 nuclear extracts prepared at 0 (uninfected), 4, 8, 12, 16, 24 , and 34 h p.i. (Fig. 2A  through F) . Although the signal produced with uninfectedcell nuclear extracts was relatively weak, there was a marked increase in the intensity of the runoff transcript from most templates employing nuclear extracts prepared at 4 and 8 h p.i. (Fig. 2A through F Fig. 2A) . For a description of the graph, see the legend for Fig. 2. 2A through F, lanes 4 and 5). In vitro transcription was also examined for IE-1 by using a template described previously (15) . We found that IE-1 showed an activation profile similar to those of the other templates (Fig. 2) , being activated maximally at 8 h p.i. and showing about 10-fold stimulation (data not shown).
No transcription was observed from late promoters. The pHR39K and p64CAT-319 templates contain both early and late promoter elements that are utilized in vivo (2, 10) (see Fig. 7 ). There was no evidence for specific transcription from late promoters by extracts from late-infected cells ( Fig.  2A and B) .
Presence of the baculovirus enhancer sequence hr5 on templates did not increase levels of in vitro transcription. The AcMNPV genome has several homologous repeated (hr) sequences (6) that contain palindromes centered around EcoRI sites. Fusion of hr sequences to a 39K-CAT construct was shown to result in enhanced levels of CAT activity when the construct was transfected into cells along with a plasmid containing IE-1 (12) . Nuclear extracts from Sf9 cells were tested for enhancer sequence-dependent activation of in vitro transcription (Fig. 3) by using several constructs. In the first tests, a plasmid containing the hr5 enhancer element upstream of the AcMNPV 39K gene promoter was used (Fig. 1A, pHR39K) . Digestion of pHR39K with SstI, which leaves the hr5 region intact and located in cis to the 39K promoter region, resulted in a runoff transcript of 214 nt, using nuclear extracts prepared from uninfected cells (Fig. 3,  lane 3) . Double digestion of the same plasmid with SstI and EcoRI, which destroyed the enhancer element but left the promoter intact, failed to reduce the level of transcription (Fig. 3, lane 4) . Similar results were obtained when nuclear extracts produced from cells at 8 h p.i. were tested with these templates (Fig. 3, lanes 1 and 2) . A repeat of this experiment with two different templates, p39K (without hr5; Fig. 1A ) and pHR39K (containing hr5; Fig. 1A Fig. 4 , whereas the positions of the mRNA start sites in the corresponding DNA sequences are shown in Fig. 5 .
The in vitro transcription start sites of the 39K gene and the OpMNPV p26 gene (Fig. 4A and B) are identical to the start sites published for in vivo RNA (1, 10) . However, the AcMNPV p26 gene primer extension product from in vitro RNA mapped to a transcription start site 17 nt upstream of the one previously suggested (17, 20) (Fig. 4C) . This site was confirmed by primer extension analysis of in vivo mRNA (Fig. 6A) . In vitro transcription of pDNAP showed a runoff transcript of about 218 nt (Fig. 2F) . Our attempts to map the in vitro transcription start sites by primer extension were unsuccessful (probably because the RNA concentration produced by uninfected-cell extracts was so low). However, we did map the in vivo DNA polymerase mRNA start site and found a major start site (Fig. 5 and Fig. 6B ) located 122 bp upstream of the DNA polymerase ATG, which corresponds to one of the major start sites previously reported (24) . Initiation from this site would produce a runoff transcript similar in size to that observed by in vitro transcription assays. Therefore the in vitro and in vivo DNA polymerase RNA appear to initiate at the same site. Primer extension products were synthesized by using RNA produced by uninfected-cell nuclear extracts. 32P-labeled primer extension products and 35 S-labeled dideoxy sequencing ladders generated by using the same primer were subjected to electrophoresis on a 6% sequencing gel. RNA start sites were determined for genes p39K (A), pOpp26 (B), and pAcHRp26A (C). The primer extension product is contained in lane P. The arrows indicate the positions on the sequence of the mRNA start sites.
from Sf9 cells during a time course of AcMNPV infection. The relative levels of transcription from the AcMNPV 39K gene were analyzed by primer extension. In in vitro transcription assays, the highest levels of 39K RNA (and RNA from all other genes tested) were produced by nuclear extracts prepared at 4 and 8 h p.i. In vitro RNA levels decreased with 12-and 16-h p.i. extracts, and no detectable transcripts were present with extracts prepared at 24 h p.i. (Fig. 2A) . In contrast, in vivo early 39K RNA transcripts were first detected at low levels at 8 h p.i. and reached high levels at 12 and 18 h p.i. These transcripts were still apparent at 27 h p.i., but early transcripts were not detectable at 67 h p.i. (Fig. 7) . With the in vivo time course, late transcripts were first seen at 12 h p.i.; this late signal was very strong at 18 h p.i. but was reduced at 27 and 67 h p.i. (Fig. 7) .
Characterization of nuclease activity in nuclear extracts prepared late in infection. Nuclear extracts prepared from insect cells after 8 h p.i. showed a decline in transcriptional activity. Reduced levels of runoff transcripts were produced by using nuclear extracts prepared at 12 or 16 h p.i., whereas those prepared at 24 or 34 h p.i. showed no specific tran- scription signals. This loss of transcriptional activity occurred regardless of the template used ( Fig. 2A to C, lanes 6 and 7). Polyacrylamide gel protein profiles from uninfected and late-infected nuclear extracts incubated for 1 h at 30°C showed no evidence of protein degradation when compared with the original unincubated samples (data not shown). The decline in transcriptional activity was therefore probably not due to general proteolysis. To determine whether the reduction in transcription was due to nucleases degrading either the mRNA or the template DNA, the nuclear extracts were tested for RNase and DNase activity. When transcription products from uninfected-cell nuclear extracts (Fig. 8A, (Fig. 8A, lanes 3 and 4) . Therefore, we found no evidence of high levels of RNase activity in late nuclear extracts.
Nuclear extracts prepared during a time course of infec- tion were also tested for DNase activity by incubating the extracts with template DNA under standard transcription preincubation conditions in the presence or absence of EDTA. With extracts prepared at 0, 4, and 8 h p.i., no difference in template recovery was apparent (Fig. 8B, lanes  1, 2, and 3) . Extracts from 12 and 16 h p.i. caused a slight degradation of the DNA template in reaction mixtures from which EDTA had been omitted (Fig. 8B, lanes 4 and 5) . However, when template was incubated in extracts prepared at 24 or 34 h p.i., the DNA incubated without EDTA was almost completely degraded (Fig. 8B, lanes 6 and 7) . Therefore, it was concluded that late-infected cell nuclear extracts contained DNase activity. Nevertheless, it was possible that nuclear extracts prepared from cells late in infection contained strong DNA binding proteins that might have reduced the recovery of DNA template during phenol extraction. Therefore radiolabeled pBS-DNA, along with nonlabeled template, was added to the in vitro transcription reaction mixtures as described above. After a 60-min incubation at 30°C, DNA was precipitated with perchloric acid and centrifuged, and the radioactivity released into the supernatant was counted. In samples incubated with nuclear extracts prepared at 34 h p.i., all the radioactivity was released, indicating the presence of high levels of DNase activity (result not shown).
DISCUSSION
The data presented in this report were derived from in vitro transcription of a variety of baculovirus early genes and demonstrate that basal levels of transcription require only host RNA polymerase II and its associated transcription factors. These data suggest that there is only one category of early genes and that previous distinctions between baculovirus immediate-early and delayed-early genes are due to differences in levels of promoter activity early in infection.
Primer extension analysis of 39K RNA over a time course of infection. Primer extension lanes are designated by the hour postinfection, indicating the time at which mRNA was prepared. A sequencing ladder generated from a plasmid containing the 39K gene and the same primer as used in the primer extension analysis is indicated. E marks the start sites of the early 39K transcripts and L marks the late transcription start site.
Infected-cell nuclear extracts prepared at 4 and 8 h p.i. activated transcription of most baculovirus genes tested from 3-to 10-fold. Transactivation has been investigated in vivo by cotransfection of AcMNPV 39K or OpMNPV gp64 CAT constructs with the AcMNPV transactivating gene IE-1 into Sf9 cells (4, 11) . Although gp64 showed similar levels of transactivation in vitro and in vivo, the 39K gene was transactivated to much higher levels when measured in the in vivo system. Direct comparison of these activated levels is limited by fundamental differences in the two methods of analysis, and identical results are not necessarily expected. The activity measured by in vivo CAT assays may be amplified by multiple rounds of translation of a single mRNA and by recycling of the CAT enzyme. In contrast, in vitro transcription by infected-cell nuclear extracts involves a complex mixture likely to contain not only IE-1 and IE-N (5) but a variety of other as-yet uncharacterized viral transactivators and attenuators and is assayed solely on the basis of the levels of RNA transcribed.
The baculovirus promoters tested showed various levels of activation with infected-cell extracts. This activation of transcription could be due to a general, nonspecific improvement in the extracts, possibly as a result of more efficient extraction of transcription factors. Such extracts should cause a higher level of basal transcription from all promoters. Alternatively, the activation could be due to the presence of specific transactivators in the infected-cell nuclear extracts, in which case only targeted promoters would be expected to be activated. Our data show that different promoters were activated to different levels. The 39K and gp64 promoters were activated to the highest extent, whereas the adenovirus major late and AcMNPV p26 pro--moters were not significantly activated. These data argue against nonspecific activation and strongly suggest the involvement of specific transactivation by components of the infected-cell nuclear extracts.
Constructs containing the baculovirus enhancer hr5 were examined for elevated levels of transcription, using both uninfected-and infected-cell nuclear extracts. No evidence for enhancement was seen. Conditions or factor(s) essential for enhancement could have been either lacking or inactivated in the extracts. Similar problems could account for the lack of transcription from the late promoters present on the 39K and gp64 constructs.
The decline in activity of nuclear extracts prepared late after the initiation of infection suggested that an inhibitor of transcription was present or that nucleases or proteases may be affecting the system. We found that, although there was no evidence of high levels of RNase or protease activity in the nuclear extracts, levels of DNase activity capable of completely hydrolyzing template DNA were detected in the late-infected nuclear extracts. Wilson and Miller (25) have shown that during the course of baculovirus infection, host cell DNA is not degraded. The DNase activity we observed may be the result of viral infection, possibly caused by a turnoff of the synthesis of a host DNase inhibitor or by destabilization of cell compartmentalization (e.g., DNasecontaining lysosomes). The nuclear extraction preparation protocol may cause the release of such nucleases into the extract.
The 39K promoter was used to compare the transcriptional activity of nuclear extracts prepared at different times after the onset of infection with the levels of 39K transcripts present in the infected cells. The results indicated that the nuclear extracts supported transcription of the 39K gene at high levels well before 39K mRNA accumulated to measurable levels in infected cells. The marked contrast between these results may reflect the difference in the two methods of analysis. In vitro transcription assays measure the ability of enzymes and factors present in a nuclear extract to initiate transcription from an abundant exogenous DNA template. In contrast, primer extension analysis of in vivo RNA measures the accumulation of specific RNA transcribed from an endogenous template. This accumulation is governed by the quantity of template, the rate of transcription from the template (influenced by such factors as promoter strength and level of transactivation), the length of time RNA is allowed to accumulate, and the rate of RNA degradation. Comparison of the in vitro and in vivo data suggested that although enzymes and transcription factors necessary for high levels of transcription exist at 4 and 8 h p.i., they were not maximally exploited at this time in vivo. This may be caused by a lack of template DNA in cells infected at a relatively low multiplicity of infection or that levels of early gene mRNA may not accumulate until after DNA replication, when the number of copies of early genes in a cell is amplified, thereby permitting increased levels of transcription.
The study described in this report was designed to determine whether this in vitro system mirrored transcriptional events occurring in cells during baculovirus infection. The data we have presented indicate that the use of infected-cell nuclear extracts may prove useful for the identification of A VOL. 66, 1992 factors involved in transactivation of early genes. However, the presence of higher levels of DNase activity in nuclear extracts from late in infection complicates the use of this approach for the study of late gene regulation. In addition, factors involved in enhancement of early gene expression, through interaction with known baculovirus enhancer sequences, were not evident in these extracts. We are currently investigating the use of different extraction protocols to develop in vitro systems suitable for the investigation of all transcription events occurring during the baculovirus infection cycle.
